Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DERM - Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript


DERM - Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript

2024-03-21 20:22:02 ET

Journey Medical Corporation (DERM)

Q4 2023 Earnings Conference Call

March 21, 2024 04:30 PM ET

Company Participants

Jaclyn Jaffe - Senior Director, Corporate Operations

Claude Maraoui - Co-Founder, President and CEO

Joseph Benesch - Interim Chief Financial Officer

Dr. Srinivas Sidgiddi - Vice President, Research and Development

Ramsey Allous - General Counsel and Corporate Secretary

Conference Call Participants

Scott Henry - Alliance Global Partners

Presentation

Operator

Good afternoon ladies and gentlemen, and thank you for standing by. Welcome to Journey Medical’s Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]

Participants of this call are advised that the audio conference call is being broadcast live over the internet and is also being recorded for playback purposes. A webcast replay of the call would be available for approximately one hour after the end of the call for approximately 30 days.

I would now like to turn the call over to Jaclyn Jaffe, the company’s Senior Director of Corporate Operations. Please go ahead, Jacklyn....

For further details see:

Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript
Stock Information

Company Name: Journey Medical Corporation
Stock Symbol: DERM
Market: NASDAQ
Website: journeymedicalcorp.com

Menu

DERM DERM Quote DERM Short DERM News DERM Articles DERM Message Board
Get DERM Alerts

News, Short Squeeze, Breakout and More Instantly...